Novavax's COVID-flu combo vaccine shows strong immune response in trial

Go back to Novavax's COVID-flu combo vaccine shows strong immune response in trial
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.98 -0.07 (0.77%)
Previous Close $9.05    52 Week High $9.23 
Open $9.18    52 Week Low $1.16 
Day High $9.27    P/E N/A 
Day Low $8.91    EPS $-0.30 
Volume 1,524,965